Life Science & Health
Investing in life saving science
Healthcare is at a tipping point with rising costs, but with more and increasingly older people to care for. We need better and more cost-effective ways to treat and manage patients. We deserve better health. Nordics and Baltics are epicenters of unparalleled science and world-class technology to solve current and future healthcare issues.
Our Life Science fund invests in early-stage biotech and digital health companies who are developing life-saving or life-altering products for unmet medical needs with global potential. We love science, and we want to make a big impact with the founders we team up with.
Targetsector
Biotech & Digital Health
Targetgeo
Nordics & Baltics
Targetstage
Pre-seed to Series-A
Fundsize
€90m
Initialticket size
€250k–€3m
Our team
In The Spotlight
Blog,Venture Capital,Innovestor

READ
Life Science fund leads SEK 304 million Series B financing round for Swedish biotech company Gesynta Pharma

Blog,Venture Capital,Innovestor

READ
Innovestor Life Science Fund continues its commitment to Neumirna Therapeutics with Series A participation
